ESTRO 2024 - Abstract Book

S629

Clinical - Breast

ESTRO 2024

49. Huang YJ, Huang TW, Lin FH, Chung CH, Tsao CH, Chien WC. Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017;12(5):782 90. 50. Bazire L, De Rycke Y, Asselain B, Fourquet A, Kirova YM. Risks of second malignancies after breast cancer treatment: Long-term results. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 2017;21(1):10-5. 51. Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiotherapy and Oncology. 2013;106(1):42-9.

52. Kwast AB, Liu L, Roukema JA, Voogd AC, Jobsen JJ, Coebergh JW, et al. Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. British journal of cancer. 2012;107(3):549-55.

53. Zhang W, Becciolini A, Biggeri A, Pacini P, Muirhead CR. Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy. Breast cancer research : BCR. 2011;13(2):R38.

54. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R. Nonbreast second malignancies after treatment of primary breast cancer. International journal of radiation oncology, biology, physics. 2009;73(5):1489 92.

55. Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer. 2009;115(18):4055-63.

56. Schaapveld M, Visser O, Louwman MJ, de Vries EGE, Willemse PHB, Otter R, et al. Risk of new primary nonbreast cancers after breast cancer treatment: A Dutch population-based study. Journal of Clinical Oncology. 2008;26(8):1239-46. 57. Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. International journal of radiation oncology, biology, physics. 2007;68(2):359-63. 58. Rutqvist LE, Johansson H. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients. Acta oncologica (Stockholm, Sweden). 2006;45(5):517-27.

59. Zablotska LB, Chak A, Das A, Neugut AI. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. American journal of epidemiology. 2005;161(4):330-7.

60. Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97(6):1404-11.

61. Curtis RE, Boice JD, Jr., Stovall M, Bernstein L, Greenberg RS, Flannery JT, et al. Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer. New England Journal of Medicine. 1992;326(26):1745-51.

62. Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast cancer research and treatment. 2012;132(1):197-203.